MedAbbrev, now by innoviHealth, has been the industry standard for medical abbreviations and acronyms since 1983. Quick and easy access for hospitals, providers, coders, transcriptionists, students and researchers to over 75,000 entries. With clear and accurate standardization that is always current, medical professionals can reduce the chance of error stemming from misunderstood abbreviations.
AHA Coding Clinic® for HCPCS - 2020 Issue 4; For Your Information
New HCPCS Level II codes for monoclonal antibody therapies for COVID-19
The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the investigational monoclonal antibody therapy, bamlanivimab, on November 9, 2020. On November 21, 2020, an EUA was issued for casirivimab and imdevimab (also known as REGN-COV2 or REGEN-COV2). Casirivimab and imdevimab are to be administered together. These monoclonal antibody therapies are for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients with positive COVID-19 test results who are at high risk for progressing to severe COVID-19 and/or hospitalization.
The Centers for Medicare and Medicaid Services (CMS) has identified specific HCPCS Level II code(s) listed...
To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.
The AHA Coding Clinic for HCPCS includes:
The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
Current newsletters added each quarter
Full Archives back to 2001
Fully searchable through Find-A-Code's Comprehensive Search
Codes mentioned in articles are linked to Code Information pages
Code Information page link back to related articles
View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products: